These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12629763)
21. [Recent achievements available for the treatment of hyperuricemia and gout. Preface]. Hosoyamada M Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):315. PubMed ID: 21218662 [No Abstract] [Full Text] [Related]
22. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Jordan KM; Cameron JS; Snaith M; Zhang W; Doherty M; Seckl J; Hingorani A; Jaques R; Nuki G; Rheumatology (Oxford); 2007 Aug; 46(8):1372-4. PubMed ID: 17522099 [No Abstract] [Full Text] [Related]
23. A prescription for lifestyle change in patients with hyperuricemia and gout. Choi HK Curr Opin Rheumatol; 2010 Mar; 22(2):165-72. PubMed ID: 20035225 [TBL] [Abstract][Full Text] [Related]
24. [Time for a European perspective on cardiovascular prevention]. Nilsson PM; Perk J; Rydén L Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749 [No Abstract] [Full Text] [Related]
25. Rules of engagement: turning recommendations into results in the diagnosis and management of gout. Grainger R; Harrison AA Int J Rheum Dis; 2015 Mar; 18(3):261-3. PubMed ID: 25923604 [No Abstract] [Full Text] [Related]
26. Gout and its comorbidities. Pillinger MH; Goldfarb DS; Keenan RT Bull NYU Hosp Jt Dis; 2010; 68(3):199-203. PubMed ID: 20969552 [TBL] [Abstract][Full Text] [Related]
27. [Austrian nutrition and lifestyle recommendations for gout and hyperuricemia]. Sautner J; Eichbauer-Sturm G; Gruber J; Puchner R; Spellitz P; Strehblow C; Zwerina J; Eberl G; Z Rheumatol; 2015 Sep; 74(7):631-6. PubMed ID: 26014619 [TBL] [Abstract][Full Text] [Related]
28. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany]. Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679 [TBL] [Abstract][Full Text] [Related]
32. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty]. Beermann B Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324 [No Abstract] [Full Text] [Related]
33. [Experience of treating gout and hyperuricemia from phlegm and stasis]. Sun WF; Zhang XX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):463-4. PubMed ID: 21608212 [No Abstract] [Full Text] [Related]
35. [Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases]. Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases Zhonghua Nei Ke Za Zhi; 2017 Mar; 56(3):235-248. PubMed ID: 28253612 [TBL] [Abstract][Full Text] [Related]